UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 OR 15 (Dd) OFof ~~THE~~the Securities Exchange Act of 1934

~~SECURITIES~~Date ~~EXCHANGE~~of ~~ACT~~Report OF(Date ~~1934~~of earliest event reported): June 17, 2015

~~Date~~NUTRANOMICS, ofINC. ~~Report~~ (~~Date~~Exact name of ~~earliest~~registrant ~~event~~as ~~reported): September~~specified ~~29,~~in ~~2015~~its charter)

NUTRANOMICS, INC.


Nevada	000-53551	98-0603540
(state or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)

(Exact name of registrant as specified in its charter)


11487 South 700 East Salt Lake City, UT		84020
(address of principal executive offices)		(zip code)

~~Nevada~~ (801) 576-8350 (registrant’s telephone number, including area code)

Not Applicable (~~State~~former name or ~~Other~~former ~~Jurisdiction~~address, ofif ~~Incorporation~~changed since last report)

000-53551	98-0603540
(Commission File Number)	(IRS Employer Identification No.)

11487 South 700 East, Salt Lake City, UT	84020
(Address of Principal Executive Offices)	(Zip Code)

(801) 576-8350

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

[Item ~~] Soliciting~~3.02 Unregistered ~~material~~Sales ~~pursuant~~of toEquity ~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)~~Securities

[On ~~] Pre-commencement~~June ~~communications~~17, ~~pursuant~~2015, the Company issued 4,500,000 shares of the Company’s common stock to ~~Rule~~JMJ ~~14d-2~~Financial (b“JMJ”), in partial satisfaction of its obligations under, and the ~~Exchange~~holder’s ~~Act~~election ~~(17~~to ~~CFR~~convert ~~240.14d-~~a portion of, the $350,000 Convertible Note dated December 2~~(b))~~, 2014, with an original principal and interest amount of $68,444.44 and held by JMJ.

[On ~~] Pre-commencement~~June ~~communications~~19, ~~pursuant~~2015, the Company issued 11,921,055 shares of the Company’s common stock to ~~Rule~~Typenex ~~13e~~Co-4Investment, LLC (c“Typenex”), in partial satisfaction of its obligations under, and the ~~Exchange~~holder’s ~~Act~~election ~~(17~~to ~~CFR~~convert ~~240~~a portion of, the Secured Convertible Promissory Note dated December 2, 2014, in the face amount of $224,000 and with an original principal amount of $59,000, and held by Typenex.~~13e-4(c))~~

~~Item~~On 5July 15, 2015, the Company issued 8,453,608 shares of the Company’s common stock to KBM Worldwide, Inc.~~02 Departure~~ (“KBM”), in partial satisfaction of ~~Directors~~its orobligations ~~Principal~~under, ~~Officers;~~and ~~Election~~the holder’s election to convert a portion of, ~~Directors;~~the ~~Appointment~~Convertible Promissory Note dated April 30, 2014, with an original principal amount of ~~Principal~~$63,000 ~~Officers~~and held by KBM.

On ~~September~~July 2917, 2015, ~~Michael~~the ~~Doron~~Company ~~resigned~~issued ~~from~~9,690,000 ~~all~~shares ~~officer~~of ~~positions~~the ~~and~~Company’s ascommon astock ~~director~~to JMJ, in partial satisfaction of ~~Nutranomics~~its obligations under, ~~Inc.~~and (the ~~“Company”),~~holder’s ~~and~~election ~~Edward~~to J.convert ~~Eyring,~~a IIportion of, ~~M.D.~~the $350,000 ~~was~~Convertible ~~appointed~~Note asdated ~~Chief~~December ~~Executive~~2, ~~Officer~~2014, ~~Chief~~with ~~Financial~~an ~~Officer,~~original principal and ~~Secretary~~interest amount of ~~the~~$68,444.44 ~~Company~~and held by JMJ.

~~Edward~~On ~~“Joe”~~July ~~Eyring~~20, II2015, ~~M.D.,~~the ~~age~~Company 48issued is3,793,686 ashares ~~previously~~of ~~Board-certified~~the ~~colorectal~~Company’s ~~surgeon~~common ~~and~~stock ~~successful~~to ~~entrepreneur~~LG inCapital ~~the~~Funding, ~~healthcare~~LLC ~~industry~~(“LG”), ~~with~~in anpartial ~~extensive~~satisfaction ~~and~~of ~~successful~~its ~~record~~obligations ofunder, ~~practice~~ and ~~business development. By~~ the ~~time he entered medical school in the late 1980~~holder’s, ~~Dr.~~election ~~Eyring~~to ~~had~~convert ~~already spent nearly~~ a ~~decade~~portion ~~apprenticing~~of, ~~with~~the ~~his father~~Nutranomics, anInc. ~~orthopedic~~8% ~~surgeon~~Convertible ~~who~~Redeemable ~~treated~~Note ~~orphaned~~Due ~~children~~December in2, ~~developing~~2015, ~~nations. A fascination~~ with ~~medicine,~~an ~~coupled~~original ~~with~~principal ~~the~~amount ~~satisfaction~~ of ~~helping people in need~~$73,500 ~~ignited~~and ~~his~~held ~~interest~~by ~~in public service~~LG.

ByOn ~~the~~July ~~time~~27, he2015, ~~became~~the aCompany ~~licensed~~issued ~~physician~~8,447,368 inshares ~~1994,~~of ~~Dr.~~the ~~Eyring~~Company’s ~~had~~common ~~already~~stock ~~learned~~to ~~first-hand~~KBM, ~~about~~in ~~the~~partial ~~calamity~~satisfaction of ~~disease~~its ~~progression~~obligations inunder, ~~patients~~and ~~with~~the ~~limited~~holder’s ~~access~~election to ~~preventative~~convert ~~care~~a orportion ~~treatment.~~of, ~~Inspired~~the byConvertible ~~these~~Promissory ~~experiences,~~Note hedated ~~embarked~~April ~~upon~~30, ~~his~~2014, ~~medical career~~ with aan ~~long-range~~original ~~vision~~principal ~~toward~~amount ~~making~~of ~~quality~~$63,000 ~~medical care affordable~~ and ~~accessible~~held toby ~~anyone~~KBM.

~~During~~On 13July ~~years~~28, as2015, athe ~~colorectal~~Company ~~surgeon~~issued 10,790,000 ~~Dr.~~shares ~~Eyring~~of ~~witnessed~~the ~~devastating~~Company’s ~~results~~common ofstock ~~insufficient~~to ~~access~~JMJ, toin ~~preventative~~partial ~~care~~satisfaction orof ~~treatment.~~its Heobligations ~~had~~under, anand ~~opportunity~~the toholder’s ~~work~~election ~~with~~to convert a ~~naturopathic~~portion ~~medical~~of, ~~doctor~~the ~~and~~$350,000 ~~learned~~Convertible ~~benefits~~Note ofdated aDecember ~~more~~2, ~~integrative~~2014, ~~holistic~~with ~~approach~~an tooriginal ~~disease~~principal ~~prevention~~ and ~~cure~~interest amount of $68,444.44 and held by JMJ.

AsOn aJuly ~~medical~~29, ~~entrepreneur~~2015, ~~Dr.~~the ~~Eyring~~Company ~~gained~~issued ~~first-hand~~16,900,000 ~~knowledge~~shares of ~~how~~the ~~rate~~Company’s ~~structures~~common ~~also~~stock ~~impacted~~to ~~health~~Typenex, ~~outcomes;~~in ~~those~~partial ~~without~~satisfaction ~~insurance~~of ~~either~~its ~~went~~obligations ~~deeply~~under, ~~into~~and ~~debt~~the orholder’s ~~without~~election ~~treatment~~to ~~altogether.~~convert ~~The~~a ~~disparity~~portion ~~strengthened~~of, ~~his~~the ~~resolve~~Secured toConvertible ~~bridge~~Promissory ~~the~~Note ~~gap~~dated December 2, 2014, in ~~coverage~~the face amount of $224,000 and ~~provide~~with ~~equal~~an ~~opportunity~~original ~~for~~principal ~~anyone~~amount toof ~~maintain~~$59,000, ~~good~~and ~~health~~held by Typenex.

~~Since~~On ~~2014~~July 30, ~~Dr. Eyring has been Managing Director of Domaine Global LLC; from 2010-2013~~2015, ~~Dr. Eyring was~~ the ~~Founder,~~Company ~~CEO~~issued ~~and Chair of Simplify Rx~~8, ~~Inc.; in 2013~~433,333 ~~Dr.~~shares ~~Eyring~~of ~~was~~the aCompany’s ~~Medical~~common ~~Director~~stock atto ~~Aeromedical~~KBM, ~~Collection Services;~~ in ~~2014,~~partial ~~Dr.~~satisfaction ~~Eyring~~of ~~founded~~its ~~American~~obligations ~~Recovery Company~~under, ~~which~~and hethe ~~has~~holder’s ~~operated~~election ~~until~~to ~~the~~convert ~~present~~a ~~date;~~portion ~~from 2004-2013~~of, ~~Dr. Eyring was~~ the ~~founding~~Convertible ~~partner~~Promissory ~~and~~Note ~~Medical~~dated ~~Director~~April of30, ~~Physicians Pharmaceutical Services; from 2005-2012~~2014, ~~Dr.~~with ~~Eyring~~an ~~was~~original ~~the owner and~~ principal ~~researcher~~amount of ~~Synergies Medical Research~~$63,000 ~~LLC; from 2000-2013, Dr. Eyring was a surgeon~~ and ~~Founding~~held ~~Practice~~by ~~Leader at Integrative GI Healthcare; and from 2000-2012, Dr~~KBM. ~~Eyring was the sole proprietor of the Pelvic Floor Diagnostic Center in Murray, Utah.~~

~~Pursuant~~On toAugust ~~Dr. Eyring’s employment contract with the Company~~6, ~~entered into on September 29,~~ 2015, ~~Dr. Eyring will be compensated in~~ the ~~amount~~Company ofissued ~~$160~~8,400,000 ~~per~~shares ~~year,~~of ~~which~~the ~~shall be accrued until January 1, 2016. At such time, it will be paid in full or converted into~~ Company’s common stock atto ~~the~~KBM, ~~previous~~in ~~5-day~~partial ~~volume~~satisfaction ~~weighted average price at such time. As~~ of ~~January~~its 1,obligations ~~2016~~under, ~~Dr.~~and ~~Eyring’s annual compensation shall increase to $260,000 per year if~~ the ~~Company~~holder’s ~~revenues~~election ~~during~~to ~~the~~convert ~~October~~a 1,portion ~~2015-December 31~~of, ~~2015 period increase two-fold as compared~~ the ~~same~~Convertible ~~period~~Promissory ~~during~~Note ~~2014. Otherwise,~~dated ~~his~~April ~~annual compensation shall remain at $160~~30,~~000~~ ~~per year. If his annual compensation does increase to $260~~2014,~~000~~ ~~per year, $160,000 shall be paid in stock on a quarterly basis valued at the previous 5-day VWAP at the time of issuance,~~ with ~~the balance paid in cash. Dr. Eyring will also receive~~ an ~~additional~~original ~~equity~~principal ~~award~~amount ~~during the first year~~ of employment equal to 0.83% of the issued and outstanding common stock of the Company following the completion of each month of employment during the first year. The employment contract is terminable at the election of either party without cause upon the provision of 30 days’ notice to the other$63,000 and isheld ~~terminable~~ by ~~the Company for cause at any time~~KBM.

On August 6, 2015, the Company issued 12,595,000 shares of the Company’s common stock to JMJ, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the $350,000 Convertible Note dated December 2, 2014, with an original principal and interest amount of $68,444.44 and held by JMJ.

On August 12, 2015, the Company issued 13,583,333 shares of the Company’s common stock to KBM, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Convertible Promissory Note dated April 30, 2014, with an original principal amount of $63,000 and held by KBM.

On August 18, 2015, the Company issued 27,300,000 shares of the Company’s common stock to Typenex, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Secured Convertible Promissory Note dated December 2, 2014, in the face amount of $224,000 and with an original principal amount of $59,000, and held by Typenex.

On August 21, 2015, the Company issued 15,680,000 shares of the Company’s common stock to JMJ, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the $350,000 Convertible Note dated December 2, 2014, with an original principal and interest amount of $68,444.44 and held by JMJ.

On August 27, 2015, the Company issued 16,460,000 shares of the Company’s common stock to JMJ, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the $350,000 Convertible Note dated December 2, 2014, with an original principal and interest amount of $68,444.44 and held by JMJ.

On August 27, 2015, the Company issued 8,500,000 shares of the Company’s common stock to Evolution Capital Partners, LLC (“Evolution”), in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the $250,000 Convertible Note dated September 27, 2013, with an original principal amount of $250,000 and held by Evolution.

On September 8, 2015, the Company issued 35,400,000 shares of the Company’s common stock to Typenex, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Secured Convertible Promissory Note dated December 2, 2014, in the face amount of $224,000 and with an original principal amount of $59,000, and held by Typenex.

On October 5, 2015, the Company issued 13,583,333 shares of the Company’s common stock to KBM, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Convertible Promissory Note dated April 30, 2014, with an original principal amount of $63,000 and held by KBM.

On October 6, 2015, the Company issued 5,833,333 shares of the Company’s common stock to KBM, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Convertible Promissory Note dated April 30, 2014, with an original principal amount of $63,000 and held by KBM.

On October 6, 2015, the Company issued 13,583,333 shares of the Company’s common stock to KBM, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Convertible Promissory Note dated April 30, 2014, with an original principal amount of $63,000 and held by KBM.

On October 7, 2015, the Company issued 19,464,286 shares of the Company’s common stock to KBM, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Convertible Promissory Note dated April 30, 2014, with an original principal amount of $63,000 and held by KBM.

On October 8, 2015, the Company issued 19,464,286 shares of the Company’s common stock to KBM, in partial satisfaction of its obligations under, and the holder’s election to convert a portion of, the Convertible Promissory Note dated April 30, 2014, with an original principal amount of $63,000 and held by KBM.

The securities issued above were issued pursuant to exemptions from registration requirements relying on Section 4(a)(2) of the Securities Act of 1933 and upon Rule 506 of Regulation D of the Securities Act of 1933 as there was no general solicitation, and the transactions did not involve a public offering. The holders provided legal opinions pursuant to Section 4(a)(1) of the Securities Act and Rule 144.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~Registrant~~registrant has duly caused this report to be signed on its behalf by the undersigned ~~thereunto~~hereunto duly authorized.

Date: October 5, 2015


Date: October 12, 2015	NUTRANOMICS, INC.

	By: /s/ Edward J. Eyring, II
	Edward J. Eyring, II
	Chief Executive Officer

NUTRANOMICS, INC. By: /s/ Edward J. Eyring, II Edward J. Eyring, II Chief Executive Officer

Filing Compare · NUTRANOMICS, INC.